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ttp://dx.doi.org/10.1016/j.ajpath.2014.03.011Endometriosis is an estrogen-dependent inﬂammatory disorder characterized by the presence of
endometrial tissue outside the uterine cavity. Patients experience chronic pelvic pain and infertility,
with the most likely origin of the tissue deposits (lesions) being endometrial fragments shed at menses.
Menstruation is an inﬂammatory process associated with a dramatic increase in inﬂammatory mediators
and tissue-resident immune cells. In the present study, we developed and validated a mouse model of
endometriosis using syngeneic menstrual endometrial tissue introduced into the peritoneum of
immunocompetent mice. We demonstrate the establishment of endometriotic lesions that exhibit
similarities to those recovered from patients undergoing laparoscopy. Speciﬁcally, in both cases, lesions
had epithelial (cytokeratinþ) and stromal (vimentin/CD10þ) cell compartments with a well-developed
vasculature (CD31þ endothelial cells). Expression of estrogen receptor b was increased in lesions
compared with the peritoneum or eutopic endometrium. By performing experiments using mice with
green ﬂuorescent proteinelabeled macrophages (MacGreen) in reciprocal transfers with wild-type mice,
we obtained evidence that macrophages present in the peritoneum and in menses endometrium can
contribute to the inﬂammatory microenvironment of the lesions. In summary, we developed a mouse
model of endometriosis that exhibits similarities to human peritoneal lesions with respect to estrogen
receptor expression, inﬂammation, and macrophage inﬁltration, providing an opportunity for further
studies and the possible identiﬁcation of novel therapies for this perplexing disorder. (Am J Pathol
2014, 184: 1930e1939; http://dx.doi.org/10.1016/j.ajpath.2014.03.011)Supported by MRC Programme grant G1100356/1 (P.T.K.S.), Wellbeing
of Women grant R42533 (A.W.H.), and a Society for Endocrinology early
career grant (E.G).
Disclosures: None declared.Endometriosis occurs in 6% to 10% of women of repro-
ductive age,1 is associated with chronic pelvic pain and
infertility, and represents a huge socioeconomic burden.2
The deﬁning feature of the condition is the presence of
endometrial tissue outside the uterine cavity, typically on
the peritoneal wall3 or the surface of the ovary (endome-
triomas).4 Spontaneous endometriosis occurs only in
humans and some primates,5,6 where the luminal portion of
the endometrium sheds at the end of the menstrual cycle.
The primary cause of endometriosis is widely accepted to be
the introduction of endometrial tissue into the peritoneal
cavity via the fallopian tubes, a process known as retrograde
menstruation.7 In captive baboons, the incidence ofstigative Pathology.
.spontaneous endometriosis parallels the number of men-
strual cycles experienced, providing a link between shed-
ding of endometrial tissue and the onset of disease.8
Current treatment strategies for peritoneal endometriosis
are restricted to surgical excision of the lesions or sup-
pression of ovarian function to mimic premature meno-
pause. In up to 75% of cases, symptoms recur after surgery,
with long-term ovarian suppression sometimes ineffective.9
A New Mouse Model of EndometriosisAlthough it is acknowledged that there is an unmet clinical
need for new nonsurgical treatments for endometriosis, their
development depends on access to animal models that can
recapitulate features of the human disorder.10 Nonhuman
primates offer a physiologically relevant model of endo-
metriosis, although their use is limited by cost and ethical
concerns. Injecting female baboons with autologous men-
strual endometrium into the peritoneal cavity has been
shown to result in the development of endometriotic le-
sions.11 This model has been used in longitudinal studies,
allowing new insights into changes in gene expression in
lesions as they become established.12 In studies using the
same model, expression of aromatase and the b isoform of
estrogen receptor (ERb) was found to be increased in the
lesions, a ﬁnding in agreement with studies in women.13,14
Rat and mouse models of endometriosis have also been
developed, offering the advantage of lower cost and smaller
animal size for testing potential therapies. The availability of
mice genetically engineered to express ﬂuorescent marker
proteins15,16 or targeted deletion of genes implicated in
endometrial disease progression17 has made them an
attractive alternative to primate studies. To date, studies
using mice have usually involved the injection of human
endometrial tissue into immunosuppressed mice18 or the
introduction of small fragments of mouse uterine tissue that
are sutured to the peritoneum or other sites (reviewed in
Grummer19). Results obtained using both models have
provided new insights into the origins of the disorder and its
association with infertility20 and have served as a platform
for testing potential therapies, including those targeting
angiogenesis in the lesions21; however, both models have
limitations. For example, although human tissue injected
either under the skin or into the peritoneal cavity can result
in the formation of endometriosis-like lesions, these can
grow only if the recipients lack the capacity to mount a
tissue rejection response, eg, they are homozygous for the
PrkdcSCID mutation.18 Models using mice with an intact
immune system allow for studies on the role(s) of inﬂam-
matory cytokines and immune cells,22,23 but because mice
do not exhibit spontaneous decidualization or menstruation,
the uterine tissue introduced into the peritoneal cavity does
not recapitulate the tissue microenvironment at the time of
retrograde menstruation. Furthermore, in most of the
autologous/syngeneic mouse models, uterine tissue is
secured in the cavity after local abrasion and/or using su-
tures,16,22 with both procedures likely to induce an artiﬁcial
inﬂammatory response.
In the present study, we set out to develop a mouse model
of endometriosis that would combine the best features of the
current baboon and mouse models. For this we used our
recently validated mouse model of menstruation24 as the
source of syngeneic mouse menstrual endometrium and
introduced this into the peritoneum of immunocompetent
mice. To determine whether this approach could mimic the
estrogenic and inﬂammatory features of human peritoneal
lesions, we examined gene and protein expression in miceThe American Journal of Pathology - ajp.amjpathol.organd patients and complemented these studies by undertaking
reciprocal transfers between mice in which cells of the
granulocyte/macrophage lineage were labeled with green
ﬂuorescent protein (GFP).15
Materials and Methods
Animals
Mature (approximately 8-week-old) female C57BL/6 mice
were purchased from Harlan Laboratories (Derby, UK) and
were allowed to acclimate for 1 week before surgery. Some
experiments were performed using transgenic Cfs1r-EGFP
mice (MacGreen) that were originally generated as
described in detail elsewhere.15 The founder stocks were a
gift from Bernadette Dutia and Prof. David Hume (The
Roslin Institute, The University of Edinburgh). Two het-
erozygous enhanced GFPþ males and two heterozygous
enhanced GFPþ females were cross-bred with wild-type
(WT) C57BL/6 mice to form a breeding colony and were
bred under standard conditions. Offspring were genotyped
and classiﬁed as either MacGreen or WT. Mice were
maintained on standard chow and water available ad libitum
and were housed in environmentally controlled facilities
illuminated between 7:00 AM and 7:00 PM. All the animal
procedures were performed in accordance with UK legal
requirements and under licensed approval from the UK
Home Ofﬁce (London).
Mouse Model of Endometriosis
Menstruation was induced in adult donor mice (approxi-
mately 8 weeks of age) using a protocol developed in-house24
(Figure 1A). In brief, ovariectomized mice (day 1) were
primed with s.c. injections of 100 ng of estradiol-17b (days 7
to 9), treated with progesterone (P4; Sigma-Aldrich, Dorset,
UK) delivered via a SILASTIC implant (Dow Corning Corp,
Midland, MI) from days 13 to 19, and injected with 5 ng of
estradiol-17b in sesame oil on days 13, 14, and 15. Decidu-
alization was induced in one uterine horn using 20 mL of oil
(day 15), and endometrial tissue in the process of being shed
from the decidualized horn was recovered from mice culled
on day 19, 4 hours after P4 withdrawal (removal of pellet) by
opening the horn longitudinally in a petri dish and scraping
the tissue away from the myometrial layer using a scalpel
(Figure 1, B and C). The tissue mass was suspended in 0.2
mL of PBS and passed through a 19-gauge needle before
being injected i.p. into anesthetized recipient mice (approx-
imately 8 weeks of age) that had been previously ovariecto-
mized and implanted with an estradiol-17b (Sigma-Aldrich)
SILASTIC implant (Figure 1A). Tissue from one decid-
ualized donor horn was used to inoculate each recipient
mouse (approximately 40 mg tissue/0.2 mL PBS per mouse).
Three weeks after i.p. injection, recipient mice were culled
(photographs of the body cavity taken and were taken the
lesions carefully dissected from surrounding tissue) and1931
Figure 1 A novel mouse model of endometriosis. A: Schematic showing the timeline of procedures performed on donor and recipient mice. Four hours after
P4 withdrawal, mouse menstrual material was collected from donor uteri. The decidualized uterine horn was selected (arrow) and opened longitudinally (B),
and the endometrium was removed from the myometrial layer, cut using a scalpel, and resuspended in PBS (C). The tissue was injected into the peritoneum of
recipient mice previously primed with an estradiol-17b SILASTIC pellet, and the lesions were allowed to develop for 3 weeks. D: Lesions recovered from
recipient mice. The white arrow indicates a neutral lesion associated with the bladder mesentery; red arrow, a peritoneal brown/black lesion.
Table 1 Patient Characterization
Characteristic Endometriosis No endometriosis
Sample size (No.) 19 18
Age [years (means  SD)] 33.68  6.903 32.38  9.193
Proliferative stage (No.) 8 8
Secretory stage (No.) 11 10
Greaves et altissues were either ﬁxed in 4% normal buffered formalde-
hyde for histologic analysis or placed in RNA Save (Gene-
ﬂow Ltd, Lichﬁeld, UK) for RNA extraction. In total,
endometriosis was induced in 18 mice. Of these, 10 mice
were used in the MacGreen reciprocal transfers: MacGreen
donor and WT recipient (n Z 6) and WT donor and Mac-
Green recipient (nZ 4).
Human Tissue Collection
Peritoneal endometriotic lesion biopsy samples (n Z 19)
were obtained from women (aged 18 to 45 years) under-
going laparoscopic surgery for the treatment of
endometriosis-associated pain. Endometrial (n Z 18) and
peritoneal (n Z 19) biopsy samples were obtained from
women undergoing an explorative laparoscopy for pelvic
pain in which no endometriosis was detected (controls). All
the samples were collected after informed consent was
provided, and ethical approval was obtained from the
Lothian Research Ethics Committee. Eighty-two patients
were recruited, but samples from those subsequently found
to have been taking exogenous hormones up to 3 months
before sample collection were not used, and as a result
samples from 37 patients were analyzed for the present
study. Cycle stage was determined by serum estrogen and1932progesterone levels and by histologic staining based on
Noyes criteria,25 and samples recovered from the prolifer-
ative and secretory phases were analyzed. Further details are
available in Table 1. Biopsy samples were collected in
RNAlater reagent (Applied Biosystems, Warrington, UK)
for quantitative RT-PCR and in neutral-buffered formalin
for immunohistochemical (IHC) analysis.
Immunodetection
After ﬁxation, human and mouse lesions were stained using
H&E; only lesions containing identiﬁable stromal and
epithelial compartments were used for further analysis.
Single-color IHC analysis was performed according to
standard protocols24,26 with citrate antigen retrieval fol-
lowed by blocking endogenous peroxidase with 3% H2O2 in
methanol. A streptavidin-biotin block (Vector Laboratories,
Peterborough, UK) was performed, and any nonspeciﬁcajp.amjpathol.org - The American Journal of Pathology
Table 2 List of Antibodies Used in IHC Analysis
Antibody speciﬁcity (supplier) Raised in Used on Dilution
ERb [AbD Serotec (#MCA1974S)] Mouse Human 1:50
ERb [Santa Cruz Biotechnology (#SC-8974)] Rabbit Mouse 1:500
ERa (Vector Laboratories) Mouse Human and mouse 1:50
CD31 (Dako) Rabbit Mouse 1:800
Cytokeratin [Sigma-Aldrich (#C2562)] Mouse Mouse 1:2000
Vimentin [Cell Signaling Technology Inc. (#5741)] Rabbit Mouse 1:600
GFP [Invitrogen Molecular Probes (#A11122)] Rabbit Mouse 1:250
Biotinylated anti-mouse (Vector Laboratories) Goat 1:500
Biotinylated anti-rabbit (Vector Laboratories) Goat 1:500
Horseradish peroxidaseeconjugated streptavidin (Dako) NA 1:200
NA, not applicable.
A New Mouse Model of Endometriosisstaining was reduced using species-speciﬁc blocking solu-
tion (1:4 serum in Tris-buffered saline þ 5% bovine serum
albumin). Incubation with the appropriate dilution of pri-
mary antibody was performed overnight at 4C in blocking
solution (Table 2). Biotinylated secondary antibodies
(dilution 1:500) were diluted in blocking solution and
incubated at room temperature for 30 minutes. A strepta-
vidinehorseradish peroxidase conjugate (dilution 1:1000;
Sigma-Aldrich) was diluted in Tris-buffered saline and
incubated at room temperature for 1 hour, followed by
visualization using ImmPACT diaminobenzidine peroxidase
substrate (Vector Laboratories). For anti-CD31 IHC anal-
ysis, nonspeciﬁc epitopes were blocked with Bloxall
blocking solution (Dako UK Ltd, Ely, UK), and the sec-
ondary antibody was detected using a streptavidinealkaline
phosphatase conjugate and visualized using PermaRed
(Dako UK Ltd). Images were captured using AxioVision
software version 4.8.2.0 (Carl Zeiss Ltd, Cambridge, UK)
and a Provis microscope (Olympus America Inc., Center
Valley, PA). Dual immunoﬂuorescence was performed as
previously herein with a secondary F (ab) polyclonal anti-
body to IgG (horseradish peroxidase), and antibody detec-
tion was performed using a TSA system kit (PerkinElmer,
Waltham, MA) labeled with either Cy3 (red) or ﬂuorescein
(green). For detection of the second antigen, sections were
microwaved for 2.5 minutes in boiling citrate buffer, and the
second primary antibody was applied overnight at 4C.
Secondary antibody was detected as before with an appro-
priate TSA system, and sections were counterstained with
DAPI (dilution 1:500). Slides were mounted in PermaFluorTable 3 List of Primer Sequences
Species mRNA Forward
Human ERa 50-TTACTGACCAACCTGGCAGA
Human ERb 50-ATCATGGAGGGTCAAATCCA
Mouse ERa 50-GCTCCTAACTTGCTCCTGGA
Mouse ERb 50-CCTCAGAAGACCCTCACTGG
Mouse IL-6 50-GCTACCAAACTGGATATAAT
Mouse CCL2 50-CATCCACGTGTTGGCTCA-3
Mouse CCL5 50-TGCAGAGGACTCTGAGACAG
Mouse TNFa 50-CTGTAGCCCACGTCGTAGC-
The American Journal of Pathology - ajp.amjpathol.orgmedium (Thermo Fisher Scientiﬁc, Waltham, MA). Sec-
tions were evaluated using an LSM 710 confocal micro-
scope and ZEN 2009 software (Carl Zeiss Ltd).
Quantitative RT-PCR
Total RNA was extracted from mouse and human tissues by
homogenization in TRI Reagent solution (Life Technologies
Ltd, Paisley, UK) using a Qiagen TissueLyser system at 25
Hz for 2.5 minutes, chloroform phase separation was per-
formed, and the lysates were processed using an RNeasy kit
(Qiagen Inc., Valencia, CA). Complementary DNA was
synthesized using a SuperScript VILO kit (Invitrogen,
Paisley, UK), with a starting template concentration of
approximately 100 ng of RNA. Real-time PCR reactions
were performed using the Roche Universal ProbeLibrary
(Roche Applied Science, West Sussex, UK) and express
quantitative RT-PCR supermix (Invitrogen). Quantitative
RT-PCR was performed using a 7900 fast real-time PCR
machine (Life Technologies, Grand Island, NY), with 18S
as the endogenous control. Primer sequences are supplied in
Table 3.
Statistical Analysis
Statistical analysis was performed using a D’Agostino and
Pearson omnibus normality test followed by a one-way
analysis of variance with a Newman-Keuls post-test or a
Student’s unpaired t-test. Graphpad Prism 5 (GraphPad
Software Inc., San Diego, CA) was used to perform the
statistical tests.Reverse
-30 50-ATCATGGAGGGTCAAATCCA-30
-30 50-TGGGCATTCAGCATCTCC-30
C-30 50-CAGCAACATGTCAAAGATCTCC-30
-30 50-CACGCACTTCCCCTCATC-30
CAGGA-30 50-CCAGGTAGCTATGGTACTCCAGAA-30
0 50-GATCATCTTGCTGGTGAATGAGT-30
C-30 50-GAGTGGTGTCCGAGCCATA-30
30 50-TTGAGATCCATGCCGTTG-30
1933
Figure 2 Mouse lesions mimic human histological phenotypes. H&E stain of mouse lesions recovered from the anterior parietal peritoneum (A), the mesentery
associated with the intestines (B), the parietal peritoneumeassociated ﬂuid-ﬁlled cyst (E), and the posterior parietal peritoneum (F). C, D, G, and H:Human lesions
recovered from the peritoneal lining. A, adipose; G, glands; H, hemosiderin; L, cyst lumen; S, stroma. Asterisk in A indicates evidence of hemorrhage.
Table 4 Information about Lesions Recovered from the Mouse
Model and Patients
Variable Mouse Human
Sample size (No.) 18 20
Recovery rate (%) 83.3 100
Number of lesions (mean  SD) 2.06  0.32 1
Lesions with glands and stroma (%) 81 68
Greaves et alResults
Mouse and Human Endometriotic Lesions Share
Common Histological Phenotypes
We developed a syngeneic mouse model of endometriosis
using mouse menstrual donor tissue to inoculate the perito-
neum of recipient mice (Figure 1A). Although the eutopic
endometrium of mice exhibits inherent differences to the
human counterpart (it does not shed), we conﬁrmed compa-
rable histological features at corresponding cycle stages
(Supplemental Figure S1). Speciﬁcally, during the estrogen-
dominated estrous stage, glands in the mouse uterus were
small and round (Supplemental Figure S1A), as were those
present in proliferative stage human endometrium
(Supplemental Figure S1C). In diestrous, glands were larger
and tortuous (Supplemental Figure S1B), comparable with
secretory phase human endometrium (Supplemental
Figure S1D). After induction of decidualization and 4
hours after P4 withdrawal, mice were culled, the uterus was
recovered (Figure 1B), and endometrial tissue was suspended
in PBS (Figure 1C). Three weeks after i.p. injection of donor
material, lesions were identiﬁed on the anterior and posterior
walls of the parietal peritoneum (Figure 1D); adipose tissue
surrounding the bladder (Figure 1D); visceral peritoneum
covering the uterus, gut, and intestines; mesentery associated
with the gut and intestines; adipose associated with the kid-
ney; and underneath the kidneys. In agreement with obser-
vations made in the patients, lesions in the mice exhibited
both macroscopic and microscopic heterogeneity. Pheno-
types observed included brown/black lesions (Figure 1D); on
histologic examination, these lesions demonstrated evidence
of hemosiderin and/or hemorrhage (Figure 2A). Lesions that
were neutral in color (Figure 1D) were surrounded by adipose1934tissue (Figure 2B), and some lesions also had ﬂuid-ﬁlled
cysts (Figure 2E). The histologic features of these mouse
lesions were similar to those recovered from patients: ﬁbrotic
lesions containing evidence of hemosiderin (Figure 2C), le-
sions with associated adipose tissue (Figure 2D), and those
with a cystic appearance (Figure 2G). Lesions in mice
(Figure 2, A, B, E, and F) and humans (Figure 2, D and H)
had a well-developed glandular epithelium. A high propor-
tion of mice (83.3%) developed lesions (Table 4); a mean of
2.06 lesions were recovered from each mouse, and 81% of
these contained both glandular and stromal compartments
(Table 4). Not all the injected material adhered to the peri-
toneum, with some ﬂoating material detected at harvest,
consistent with reports from other researchers.27
Immunostaining was used to identify cells with an
epithelial phenotype (anti-cytokeratin) (Figure 3B), stromal
ﬁbroblasts (anti-CD10) (Figure 3D), and endothelial cells in
the vasculature (anti-CD31) of human lesions (Figure 3F),
with identical cell types conﬁrmed in the lesions from mice
(Figure 3, A, C, and E). The recovered lesions were
signiﬁcantly more vascularized compared with the perito-
neum in both mice (means  SEM: 133.1  19.62 and
44.55  26.54, respectively; P < 0.05) (Figure 3G) and
humans (511.6  159.1 and 116  25.7, respectively;
P < 0.05) (Figure 3H).ajp.amjpathol.org - The American Journal of Pathology
Figure 3 Mouse and human lesions possess glandular, stromal, and
vascular components. In lesions recovered from mice (A, C, and E) or
women (B, D, and F), IHC analysis identiﬁed cytokeratin-positive epithelial
cells (brown positive) (A and B) and stromal ﬁbroblasts (C, vimentin; D,
CD10, brown positive in both cases). Endothelial cells were immunopositive
for CD31 in mice (E, PermaRed) and humans (F, diaminobenzidine). Insets
in A and B show negative controls with omission of primary antibody. G
and H: When blood vessels were quantiﬁed in peritoneum and lesions (nZ
5 mice; nZ 5 humans for each sample type), a signiﬁcantly higher density
was detected in the lesions. Data are expressed as means  SD. *P < 0.05
by Student’s t-test.
Figure 4 ER expression is comparable in mouse and human lesions. A:
Quantitative RT-PCR analysis of ERa (black bars) and ERb (white bars) in
the mouse uterus (n Z 6), peritoneum (n Z 6), and endometriotic
(Endo) lesions (nZ 6). B: Quantitative RT-PCR analysis of ERa and ERb in
human endometrium (Endo) (n Z 18), peritoneum (n Z 19), and peri-
toneal lesions (n Z 19). Quantitative RT-PCR data were analyzed using a
one-way analysis of variance and the Newman-Keuls postcomparison test.
C: Diaminobenzidine (DAB) IHC analysis using an anti-ERa antibody on
mouse lesions revealed moderate immunoreactivity in glandular epithe-
lium. D: DAB IHC analysis using an anti-ERa antibody on human lesions
also revealed moderate immunoreactivity in epithelium and stromal areas.
Insets in C and D show negative controls with omission of primary
antibody. E: DAB IHC analysis using an anti-ERb antibody on mouse le-
sions reveals prominent ERb immunoreactivity in glandular epithelium
and stromal regions. F: DAB IHC analysis using an anti-ERb antibody on
human lesions also reveals strong immunoreactivity in glandular and
stromal regions. IHC analysis of human lesions was performed on samples
dissected during the proliferative (estrogen-dominated) stage of the
menstrual cycle. Data are expressed as means  SD. *P < 0.05,
**P < 0.01, and ***P < 0.001. RQ, relative quantiﬁcation.
A New Mouse Model of EndometriosisChanges in ER Subtype Expression in Human Peritoneal
Lesions Is Mirrored by Expression in the Endometriotic
Lesions Recovered from Mice
We previously reported patterns of expression of ERa and
ERb during the normal cycle in human28 and mouse29
endometrium. Concentrations of ERa mRNAs were signif-
icantly lower in lesions compared with the endometrium in
mice (Figure 4A) and humans (Figure 4B) (P < 0.001 and
P < 0.01, respectively). In contrast, concentrations of ERb
mRNA in tissue homogenates of lesions were signiﬁcantly
higher than in the endometrium in mice (Figure 4A) and
humans (Figure 4B) (P < 0.05 for both). Additional data for
patient samples comparing the proliferative and secretory
phases are given in Supplemental Figure S2; the only sig-
niﬁcant difference between cycle stages was that theThe American Journal of Pathology - ajp.amjpathol.orgexpression of ERa in lesions in the secretory phase was
higher than in the proliferative phase.
ERa protein was localized to the glandular epithelium of
mouse lesions (Figure 4C), but rarely in the stromal compart-
ment. In contrast, ERb IHC analysis revealed intense immu-
noreactivity in lesions inmultiple cell types, including glandular
epithelial, stromal ﬁbroblast, and endothelial cells (Figure 4E).
Analysis of human lesions detected staining for ERa in stromal
and epithelial cells (Figure 4D), with intense ERb immuno-
positive staining in multiple cell types (Figure 4F).1935
Figure 5 Analysis of expression of cytokines in mouse tissues revealed
altered expression in lesions. Quantitative RT-PCR analysis of inﬂammatory
cytokines in the uterus (NU) and peritoneum (NP) of healthy cycling mice
and the peritoneum (EP) and lesions (EL) of mice with endometriosis: IL-6
(A), TNFa (B), CCL2/macrophage chemotactic protein 1 (C), and CCL5/
RANTES (D). Quantitative RT-PCR data were analyzed using a one-way
analysis of variance and a Newman-Keuls post-comparison test. Data are
expressed as means  SD. *P < 0.05, ***P < 0.001.
Figure 6 Macrophages from the shed endometrium contribute to
endometriotic lesions. A and B: In human peritoneal lesions, immuno-
staining for CD68 identiﬁed macrophages in the stroma, some of which were
in close proximity to glandular structures in human lesions. The inset in A
shows an enlarged image of stromal macrophages; in B, the inset shows
negative control with omission of primary antibody. White arrows indicate
macrophages (B). C: Schematic indicating reciprocal transfers of menstrual
material between MacGreen mice (green) and WT mice (brown). D: Anti-GFP
IHC analysis on MacGreen donor uteri 4 hours after P4 withdrawal revealed
macrophages present in the decidua and associated with the uterine lumen
(inset). Black arrows indicate an area of the decidua beginning to shed from
the basal layer of the endometrium. E: GFPþ macrophages were detected
using an anti-GFP antibody in lesions isolated from MacGreen (donor) to WT
(recipient) mice, demonstrating the presence of macrophages from the shed
endometrium in lesions. Black arrows indicate macrophages. F: GFPþ
macrophages were also detected in lesions isolated from WT (donor) to
MacGreen (recipient) mice, demonstrating inﬁltration of host macrophages
into lesions. The inset shows negative control with omission of primary
antibody. G: Graph showing the respective contribution of donor/recipient
to the macrophage composition of mouse endometriotic lesions. Statistical
analysis was performed using a Student’s t-test. Data are expressed as means
 SD. nZ 6 (MacGreen-WT); nZ 3 (WT-MacGreen). *P< 0.05. G, glands; V,
vessels. Scale bars: 50 mmol/L (A, A, inset, and E); 20 mmol/L (B); 100 mmol/
L (B, inset); 200 mmol/L (D).
Greaves et alPeritoneal Lesions Formed in Mice Have an Altered
Cytokine Microenvironment
Concentrations of mRNAs encoding the proinﬂammatory
cytokine tumor necrosis factor a (TNFa) and the monocyte
chemoattractant proteins chemokine ligands 2 and 5 (CCL2
and CCL5) were signiﬁcantly higher in endometriotic le-
sions compared with healthy peritoneum and the peritoneum
of endometriotic mice (P < 0.001) (Figure 5, BeD). Con-
centrations of IL-6 (Figure 5A) and IL-4 (not shown) were
not signiﬁcantly different between samples.
Macrophages Present in the Shed Endometrium
Contribute to Endometriotic Lesions
We detected CD68þ macrophages in the stroma of human
peritoneal lesions in close proximity to blood vessels
(Figure 6A) and the glandular epithelium (Figure 6B). In
MacGreen mice, GFPþ cells were readily identiﬁed in the
uterus after induction of menses-like tissue shedding
(Figure 6D and Supplemental Figure S3). The GFPþ cells
were present in the endometrial/decidual tissue 4 hours after
P4 withdrawal, when tissue was recovered for transfer
(Figure 6D). The inﬂux of GFPþ cells was also conﬁrmed in
samples recovered at 12 hours, when blood could be detected
in the vagina of 100% of mice24 (Supplemental Figure S3).
After reciprocal transfers between MacGreen and WT lit-
termates (Figure 6C), GFPþ cells were detected in1936endometriotic lesions (Figure 6, E and F). Fluorescent IHC
analysis was used to show that GFPþ cells present in lesions
were all GR-1e (GR-1 antibody directed against Ly-6Cþ and
Ly-6Gþ granulocytes) (Supplemental Figure S4, BeD),ajp.amjpathol.org - The American Journal of Pathology
A New Mouse Model of Endometriosisalthough some GR-1/GFPþ cells were present in the mouse
uterus 4 hours after P4 withdrawal (Supplemental
Figure S4A). Also, in lesions containing GFPþ cells, stain-
ing of adjacent sections conﬁrmed that cells were F4/80þ
(macrophage marker) (Supplemental Figure S4, EeH), thus
validating that GFPþ cells represented a population of tissue-
resident macrophages. GFPþ macrophages were present in
lesions harvested from WT recipients after peritoneal trans-
fer of menstrual tissue from MacGreen mice (Figure 6E),
suggesting that macrophages present in shed endometrium
survive and contribute to the inﬂammatory microenviron-
ment of the lesions. The numbers of GFPþ macrophages
were higher in lesions isolated from WT (donor) to Mac-
Green (recipient) transfers (Figure 6F); this was signiﬁcant
when macrophages were counted and normalized to lesion
area (means  SEM: 12.08  4.69 and 39.64  8.034;
PZ 0.013) (Figure 5G). We found that GFPþ macrophages
were present close to the glandular compartments of lesions
(Supplemental Figure 5A) and around the edges of lesions,
close to blood vessels (Supplemental Figure S5B). In some
lesions, GFPþ macrophages also seemed to be migrating
toward the lesion from adjacent blood vessels (Supplemental
Figure S5C) and were present in ﬁbrotic areas of lesions
(Supplemental Figure S5D).
Discussion
In this study, we describe a new mouse model of endome-
triosis that uses syngeneic mouse menstrual donor tissue
introduced into the peritoneum of immunocompetent
recipient mice. This model mimics the primate baboon
model, in which lesions are artiﬁcially induced by the in-
jection of menstrual endometrium into the peritoneum,11 but
is distinct from previously described mouse models, in
which uterine tissue fragments are sutured onto the perito-
neum16 or intestinal mesentery.30 To determine whether the
use of menstrual material could recapitulate key features of
the human disorder in mice, we examined lesions for evi-
dence of endometrial histology, ER expression, inﬂamma-
tory signaling molecules, and tissue-resident macrophages.
In the present study, lesions recovered from a variety of
sites in the peritoneum of the mice shared histological
similarities with human lesions, including the presence of
hemosiderin, cytokeratin-positive epithelial cells, and close
association with adipose cells. Lesions recovered from other
mouse models frequently possess a cystic phenotype,31 and
although we did observe this histological feature, most le-
sions had evidence of well-organized stromal and glandular
structures. In the mice, total concentrations of ERb mRNAs
were signiﬁcantly higher in lesions compared with the
endometrium and peritoneum, and intense immunostaining
was detected in all cell types. In contrast, expression of ERa
in the mouse lesions was lower than in the uterus. The
ﬁndings in this new mouse model seem to phenocopy re-
sults obtained in lesions recovered from the patients and are
in agreement with reports that alterations in the DNAThe American Journal of Pathology - ajp.amjpathol.orgmethylation status of the ESR2 gene promoter is a mecha-
nism responsible for the increase in ERb mRNAs in endo-
metriotic cells.32 In the healthy endometrium, expression of
the P4 receptor is coupled with that of ERa,33 and altered
ratios of ERa:ERb in endometriosis lesions have been
implicated in the suppression of P4 receptor expression.34
Because we detected altered expression of ERa and ERb
in lesions in the present mice, we believe it may provide a
model for further studies on the mechanisms responsible for
the PR-resistant phenotype reported in patients with
endometriosis.34
Menstruation is an inﬂammatory process, the culmination
of a regulatory cascade of changes precipitated by the acute
withdrawal of P4 and characterized by an increase in a
variety of tissue-resident immune cells, with 6% to 10% of
cells in the menstrual endometrium reported to be macro-
phages.6,35 A complex interaction between resident immune
cells and uterine stromal cells modulates the biosynthesis
and release of proinﬂammatory cytokines, chemokines, and
prostaglandins, resulting in local vasoconstriction, release of
enzymes that degrade the extracellular matrix, and shedding
of the upper layer of the endometrium.36,37 Thus, menstrual
material, including that arriving in the peritoneal cavity by
retrograde ﬂow, will contain tissue fragments, including
their resident immune cells and a range of inﬂammatory
mediators. The importance of the inﬂammatory microenvi-
ronment of the shed endometrium has been highlighted by
reports of an altered inﬂammatory phenotype in both the
peritoneal milieu and eutopic endometrium of women with
endometriosis.38 Previous studies performed in the baboon
reported a higher number of lesions in animals injected i.p.
with menstrual endometrium compared with luteal endo-
metrium, indicating that menstrual material contains factors
that enhance its ability to attach to the peritoneal lining.39
Herein, we conﬁrmed that induction of a menses-like
event in mice was associated with the presence of macro-
phages in the uterus and that lesions formed in mice con-
tained tissue-resident macrophages and a proinﬂammatory
microenvironment. These results would be consistent with
evidence that macrophages are key players in the patho-
genesis of endometriosis. For example, Chuang et al40
suggested that prostaglandin E2emediated down-
regulation of the scavenger receptor CD36 may inhibit the
phagocytic ability of peritoneal macrophages, encouraging
the establishment of lesions. The macrophage inhibitor
factor IL-13 is decreased in women with endometriosis,41
suggesting a mechanism by which endometriosis-
associated macrophages are unrestrained. Transforming
growth factor b is overexpressed in patients with endome-
triosis; in a mouse model based on xenotransplantation of
human eutopic endometrial tissue, the weight of
endometriosis-like lesions was reduced 11-fold when tissue
was engrafted into TGFb null mice, and numbers of mac-
rophages detected in the lesions were signiﬁcantly reduced,
supporting suggestions that macrophages are involved in
lesion survival.181937
Greaves et alBy performing reciprocal transfers between MacGreen
and WT (unlabeled) mice, we could determine the source of
the macrophages in endometriosis lesions. When lesions
were recovered from MacGreen recipients, we readily
detected GFPþ macrophages in the lesions, consistent with
reports that macrophages in endometriotic lesions are
recruited from the circulation42 or from populations present
in peritoneal ﬂuid.43 In contrast, the contribution of mac-
rophages present in shed endometrium to the etiology of
endometriotic lesions has not been studied in previous
mouse models, and, therefore, we were excited to detect
GFPþ macrophages in lesions 3 weeks after the transfer of
tissue from MacGreen mice into the peritoneum of WT
recipients. These data suggest that the macrophages present
in shed endometrium persist in the peritoneal microenvi-
ronment and contribute to the endometriotic lesions. Mac-
rophages and neutrophils are thought to promote
angiogenesis in the early stages of lesion formation, and this
has been reported using an autologous mouse model using
estrous uterine tissue sutured to the peritoneum.44 We
speculate that in the present menses endometriosis model,
formation of lesions is promoted by the presence of immune
cells, including macrophages, without the need for induced
inﬂammation caused by suturing.
A variety of studies have analyzed the polarization of
macrophages present in lesions45; it has been demonstrated
that lesion-resident macrophages are alternatively activated
(M2 phenotype), exhibiting a repair/resolution phenotype
thought to enhance ectopic cell survival. Conversely, the
injection of M1-like (proinﬂammatory) macrophages may
suppress lesion development.46 The endometrial macro-
phage is thought to possess a unique phenotype that alters
during the menstrual cycle.47 This study suggests that the
population of macrophages in the lesions may be hetero-
geneous and that macrophages in shed endometrium might
survive for long periods and become reprogrammed while
resident in the tissue. Further studies are required before we
can assess the relative contributions of peritoneum, circu-
lation, and menses material to the complex immune cell
complement of the lesions.
To investigate how the presence of immune cells, such as
macrophages, affect the lesion microenvironment, we
analyzed the expression of macrophage chemotactic factors
(CCL2 and CCL5) and macrophage-derived cytokines (IL-6
and TNFa). We found that CCL2 (also known as macro-
phage chemotactic protein 1) and CCL5 (also known as
RANTES) were up-regulated in the lesions of mice with
endometriosis, consistent with reports that lesions recruit
macrophages. We also found that in lesions, TNFa was
overexpressed compared with the peritoneum, indicating
that the inﬂammatory microenvironment of lesions is altered
by the presence of macrophages. These results would be
consistent with reports that peritoneal macrophages isolated
from mice with endometriosis secrete TNFa and IL-6,
which up-regulates vascular endothelial growth factor,
leading to increased angiogenesis.441938In summary, we describe a new mouse model of endo-
metriosis that offers the chance to fully explore the patho-
biology of this complex disorder. The model closely mirrors
the human condition as an estrogen-dependent inﬂammatory
disorder, exhibiting similar hallmarks, and has revealed that
the immune complement of the menstrual endometrium
contributes to the pathologic appearance of peritoneal le-
sions. We hope that the use of this model will inform future
studies investigating the role of immune cells and menstrual
tissue on the development of endometriosis, advance our
understanding of disease mechanisms of endometriosis, and
allow the identiﬁcation and study of novel targets for
endometriosis therapy.
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